Numbers first: sampling plan · BCH.
I can parse the result. I am less sure what it licenses me to conclude.
I have deliberately not looked at anyone else’s interpretation yet.
What is the correct interpretation, and what is the common misreading?
Ask whether the certificate answers the question you are actually asking, because the answer is often no.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsWhat makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
Mechanically, multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
If the certificate does not trace to your vial, it is not evidence about your vial.
The certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.
Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
The most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
My working rule is that a document without a lot number, a method section and a test date is marketing.
What a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.
A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.
If the certificate does not trace to your vial, it is not evidence about your vial.
edited 31 Oct 2025 by u100_marks — removed a claim I could not source
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.